We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Exercise Alone Matches Diet Plus Exercise for Hip Osteoarthritis Pain Relief, Large Randomized Trial Shows

MedXY Editorial Team•Oct 1, 2025•Clinical Updates
exercisehip osteoarthritisrandomized trialweight loss

Highlights

  • In overweight or obese adults with hip osteoarthritis, a very-low-calorie diet combined with exercise did not provide greater pain relief than exercise alone.
  • Both interventions led to clinically significant reductions in hip pain at 6 months.
  • The diet-plus-exercise group achieved more weight loss and modestly better quality-of-life outcomes but not superior pain reduction.
  • No serious adverse events were associated with either intervention.

Study Background and Disease Burden

Osteoarthritis (OA) of the hip is a prevalent chronic joint condition, leading to pain, functional impairment, and reduced quality of life, particularly in adults aged 50 years and older. Overweight and obesity are widely recognized risk factors for the development and progression of hip OA, raising the question of whether intentional weight loss confers clinical benefit in this population. While weight loss is strongly recommended in knee OA, the evidence for its role in hip OA has been less robust and sometimes contradictory. There remains an unmet need for high-quality data to guide optimal non-surgical management strategies for hip OA in overweight or obese individuals.

Study Design

This Australian multicenter, two-group superiority randomized controlled trial (ClinicalTrials.gov: NCT04825483) addressed this gap by enrolling 101 adults (BMI >27 kg/m²) with radiographically confirmed hip osteoarthritis and chronic hip pain (≥3 months duration). Participants were randomized to one of two arms for 6 months:

  • Exercise Alone: Home-based exercise program with five telehealth physiotherapy consultations.
  • Very-Low-Calorie Diet (VLCD) Plus Exercise: The same exercise program, plus a ketogenic VLCD delivered via six telehealth dietitian consultations.

The primary endpoint was the change in hip pain severity at 6 months, measured on an 11-point numeric rating scale (0=no pain, 10=worst pain), with a minimum clinically important difference (MCID) of 1.8 points. Secondary outcomes included other pain metrics, Hip Disability and Osteoarthritis Outcome Score (HOOS) domains, physical function, quality of life, body weight, composition, and adverse events. Follow-up continued to 12 months post-randomization.

Key Findings

At 6 months, both groups experienced clinically meaningful reductions in hip pain severity: the exercise-only group improved by 2.0 points, and the VLCD plus exercise group by 2.8 points. However, the between-group difference in pain reduction was not statistically significant (mean difference, -0.6 points; 95% CI, -1.5 to 0.3), failing to meet the MCID and indicating no superiority of VLCD plus exercise over exercise alone for pain relief.

The VLCD plus exercise group achieved significantly greater weight loss, averaging 8.5% more than the exercise-only group. At 12 months, sustained improvements in body weight, BMI, and hip function (HOOS pain and function subscales) favored the VLCD plus exercise group. Notably, a larger proportion of the diet-plus-exercise group reached the threshold for a clinically relevant reduction in pain (≥1.8 points) at 6 months compared to exercise alone.

Quality of life outcomes showed a modest but consistent advantage for the VLCD plus exercise group at both 6 and 12 months. However, no significant between-group differences were observed in overall physical activity levels. Importantly, no serious adverse events related to the interventions were reported, supporting the safety of both approaches in this population.

A summary table is provided below:

Outcome Exercise Alone VLCD + Exercise Between-Group Difference
6-mo Hip Pain Reduction (0-10 scale) -2.0 -2.8 -0.6 (95% CI, -1.5 to 0.3)
Weight Loss (%) – 8.5% more Significant
HOOS Pain/Function (12 mo) – Favored VLCD+Ex Significant
Quality of Life (12 mo) Improved Slightly greater improvement Not statistically significant
Serious Adverse Events 0 0 None

Expert Commentary

Kim Bennell, PhD, physiotherapist and study co-author at the University of Melbourne, noted that while weight loss is a cornerstone of non-operative management for knee OA, evidence for the same approach in hip OA has lagged. This trial is one of the few rigorously designed studies to directly address the question. The results challenge the prevailing assumption that weight loss is essential for symptomatic relief of hip OA in overweight or obese adults, suggesting that a structured exercise program alone provides substantial benefit.

The observed improvements in pain and function with exercise alone reflect the established efficacy of physical activity interventions in OA, possibly via mechanisms including muscle strengthening, improved joint mechanics, and modulation of pain signaling. While the addition of a VLCD led to superior weight loss and slight quality-of-life gains, the lack of corresponding additional pain relief may indicate distinct pathophysiologic differences between hip and knee OA, or that biomechanical load reduction is less consequential for the hip joint.

Limitations of the study include the relatively short duration (6-12 months), the use of telehealth (which may limit generalizability), and exclusion of individuals with severe comorbidities or advanced OA. Longer-term data will be important to assess whether weight loss influences OA progression or need for joint replacement surgery.

Conclusion

For overweight or obese adults with hip osteoarthritis, a very-low-calorie weight loss diet combined with exercise does not provide greater pain reduction than exercise alone, although it results in more weight loss and modest quality-of-life improvement. Exercise remains the primary non-surgical intervention for hip OA pain, while the role of weight loss may be more nuanced than previously thought. Ongoing research should continue to clarify the indications for weight management in this population, particularly with regard to long-term structural outcomes.

References

1. Hall M, Hinman RS, Knox G, Spiers L, McManus F, De Silva AP, Sumithran P, Harris A, Murphy NJ, Cicuttini F, Hunter DJ, Messier SP, Bennell KL. Efficacy of a Very-Low-Calorie Weight Loss Diet Plus Exercise Compared With Exercise Alone on Hip Osteoarthritis Pain: A Randomized Controlled Trial. Ann Intern Med. 2025 Aug 5. doi: 10.7326/ANNALS-25-00045. Epub ahead of print. PMID: 40759020.
2. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019 Apr 27;393(10182):1745-1759. doi:10.1016/S0140-6736(19)30417-9.
3. Bennell KL, et al. Physical therapies in the management of osteoarthritis. Best Pract Res Clin Rheumatol. 2014 Feb;28(1):93-117. doi:10.1016/j.berh.2014.01.002.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Comparing Calorie-Restricted DASH, Carbohydrate-Restricted, and Low-Purine Diets for Weight Loss and Serum Urate Control in Men with HyperuricemiaA 12-week randomized trial compared the effects of calorie-restricted DASH, carbohydrate-restricted, and low-purine diets on weight loss and serum urate levels in men with overweight or obesity and hyperuricemia, highlighting adherence and Sep 16, 2026Evaluating Complication Rates in Post-Weight-Loss Body Contouring: Comparing Surgery, GLP-1 Pharmacotherapy, Combination, and Lifestyle ApproachesThis study investigates postoperative complication rates following body-contouring surgery among patients with differing weight-loss methods, revealing that weight-loss modality does not affect complications, while BMI and diabetes at surgeSep 3, 2026Impact of Weight-Loss Methods on Post-Bariatric Body Contouring Surgery Outcomes: A Comparative AnalysisThis study evaluates complication rates following body contouring after weight loss via bariatric surgery, GLP-1 receptor agonists, combination therapy, and lifestyle changes, finding weight-loss modality does not affect postoperative complSep 1, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Exercise Reverses Obesity-Driven Immune Dysfunction in Lung Cancer: New Insights for Therapy and PreventionPhysical activity counteracts adiposity-induced immune suppression in lung cancer and non-tumor lungs, restoring antitumor immunity and slowing tumor progression, with implications for lung cancer interception.Aug 25, 2026
Early Weight Loss in Impaired Glucose Tolerance Significantly Lowers Long-term Cardiovascular and Mortality Risks: Insights from the Da Qing Diabetes Prevention StudyEarly weight loss after impaired glucose tolerance diagnosis is linked to markedly reduced long-term risk of cardiovascular events and death, underscoring the importance of early lifestyle interventions in prediabetes management.Aug 24, 2026
Mazdutide: A Novel Dual Agonist Demonstrates Significant Weight Loss in Adults with Obesity or OverweightMazdutide, a once-weekly glucagon and GLP-1 receptor dual agonist, delivers clinically meaningful weight reduction in adults with obesity or overweight, with higher doses yielding superior outcomes and manageable safety profiles.Aug 22, 2026